CytomX Therapeutics Inc (CTMX)
NASDAQ:CTMX
Holding CTMX?
Track your performance easily

CytomX Therapeutics (CTMX) Financial Statements

562 Followers

CytomX Therapeutics Financial Overview

CytomX Therapeutics's market cap is currently ―. The company's EPS TTM is $0.169; its P/E ratio is 6.42; CytomX Therapeutics is scheduled to report earnings on February 26, 2025, and the estimated EPS forecast is $-0.22. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 33.43M$ 25.11M$ 41.46M$ 26.61M$ 26.38M
Gross Profit$ 33.43M$ 25.11M$ 41.46M$ 26.61M$ 26.38M
EBIT$ 5.80M$ -6.48M$ 11.66M$ -606.00K$ 3.12M
EBITDA$ 6.23M$ -4.16M$ 12.12M$ -120.00K$ 3.61M
Net Income Common Stockholders$ 5.74M$ -6.53M$ 13.79M$ 837.00K$ 2.99M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 117.59M$ 137.18M$ 150.28M$ 174.51M$ 194.11M
Total Assets$ 138.98M$ 159.22M$ 184.69M$ 201.79M$ 221.17M
Total Debt$ 10.60M$ 11.75M$ 12.87M$ 13.97M$ 10.60M
Net Debt$ -106.99M$ -125.44M$ -137.41M$ -160.53M$ -183.51M
Total Liabilities$ 162.43M$ 190.45M$ 216.37M$ 249.24M$ 272.40M
Stockholders Equity$ -23.45M$ -31.23M$ -31.68M$ -47.45M$ -51.24M
Cash Flow-
Free Cash Flow$ -20.75M$ -19.64M$ -26.16M$ -22.23M$ -18.25M
Operating Cash Flow$ -20.73M$ -19.55M$ -26.05M$ -21.96M$ -18.24M
Investing Cash Flow$ 18.17M$ 21.51M$ 44.88M$ 12.87M$ -42.94M
Financing Cash Flow-$ 5.10M$ 174.00K$ 244.00K$ 29.67M
Currency in USD

CytomX Therapeutics Earnings and Revenue History

CytomX Therapeutics Debt to Assets

CytomX Therapeutics Cash Flow

CytomX Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis